O	O	O	0	9	Synergism	Synergism	B-NP	NN	O	0	ROOT	O
O	O	O	10	17	between	between	B-PP	IN	O	1	NMOD	O
O	O	O	18	21	the	the	B-NP	DT	O	5	NMOD	O
T4	B-Entity	B-Entity	22	25	CD3	CD3	I-NP	NN	B-protein	5	NMOD	B-protein
T4	I-Entity	I-Entity	26	33	antigen	antigen	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	33	34	-	-	O	HYPH	O	5	P	O
O	O	O	35	38	and	and	O	CC	O	9	NMOD	O
O	O	O	39	42	CD2	CD2	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	43	50	antigen	antigen	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	50	51	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	O	51	58	derived	derive	I-NP	VBN	O	12	NMOD	O
O	O	O	59	66	signals	signal	I-NP	NNS	O	2	PMOD	O
O	O	O	66	67	.	.	O	.	O	1	P	O

O	O	O	68	79	Exploration	Exploration	B-NP	NN	O	13	NMOD	O
O	O	O	80	82	at	at	B-PP	IN	O	1	NMOD	O
O	O	O	83	86	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	87	92	level	level	I-NP	NN	O	2	PMOD	O
O	O	O	93	95	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	96	105	induction	induction	B-NP	NN	O	5	PMOD	O
O	O	O	106	108	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	109	112	DNA	DNA	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	112	113	-	-	O	HYPH	I-protein	8	P	I-protein
O	O	O	113	120	binding	bind	B-VP	VBG	I-protein	11	NMOD	I-protein
O	O	O	121	129	proteins	protein	B-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	130	133	and	and	O	CC	O	13	NMOD	O
O	O	O	134	150	characterization	characterization	B-NP	NN	O	0	ROOT	O
O	O	O	151	153	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	154	157	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	158	168	inhibitory	inhibitory	I-NP	JJ	O	17	NMOD	O
O	O	O	169	177	activity	activity	I-NP	NN	O	14	PMOD	O
O	O	O	178	180	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	181	193	cyclosporine	cyclosporine	B-NP	NN	O	18	PMOD	O
O	O	O	193	194	.	.	O	.	O	13	P	O

O	O	O	196	198	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	199	203	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	204	216	demonstrated	demonstrate	I-VP	VBN	O	2	VC	O
O	O	O	217	224	earlier	earlier	B-ADVP	RBR	O	3	VMOD	O
O	O	O	225	229	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	230	233	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	234	246	crosslinkage	crosslinkage	I-NP	NN	O	5	SBAR	O
O	O	O	247	249	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	250	253	the	the	B-NP	DT	O	18	NMOD	O
T5	B-Entity	B-Entity	254	257	CD3	CD3	I-NP	NN	B-protein	18	SUB	B-protein
T5	I-Entity	I-Entity	257	258	/	/	B-VP	SYM	O	10	NMOD	O
T5	I-Entity	I-Entity	258	261	TCR	TCR	B-NP	NN	B-protein	13	NMOD	B-protein
T5	I-Entity	I-Entity	262	269	complex	complex	I-NP	NN	I-protein	11	OBJ	I-protein
O	O	O	270	274	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	275	278	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	279	282	CD2	CD2	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	283	290	antigen	antigen	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	291	298	results	result	B-VP	VBZ	O	8	SBAR	O
O	O	O	299	301	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	302	305	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	306	319	proliferation	proliferation	I-NP	NN	O	19	PMOD	O
O	O	O	320	322	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	323	329	normal	normal	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	O	330	335	human	human	I-NP	JJ	I-cell_type	26	NMOD	I-cell_type
O	O	O	336	337	T	T	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	O	338	343	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	O	343	344	.	.	O	.	O	2	P	O

O	O	O	345	348	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	349	355	effect	effect	I-NP	NN	O	6	SUB	O
O	O	O	356	358	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	359	363	this	this	B-NP	DT	O	5	NMOD	O
O	O	O	364	373	synergism	synergism	I-NP	NN	O	3	PMOD	O
O	O	O	374	377	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	378	389	perceptible	perceptible	B-ADJP	JJ	O	6	PRD	O
O	O	O	390	392	at	at	B-PP	IN	O	7	AMOD	O
O	O	O	393	396	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	397	402	level	level	I-NP	NN	O	8	PMOD	O
O	O	O	403	405	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	406	415	induction	induction	B-NP	NN	O	11	PMOD	O
O	O	O	416	418	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	419	422	the	the	B-NP	DT	O	18	NMOD	O
T1	B-Protein	B-Protein	423	425	IL	IL	I-NP	NN	B-DNA	18	NMOD	B-DNA
T1	I-Protein	I-Protein	425	426	-	-	B-NP	HYPH	I-DNA	18	NMOD	I-DNA
T1	I-Protein	I-Protein	426	427	2	2	I-NP	CD	I-DNA	18	NMOD	I-DNA
O	O	O	428	432	gene	gene	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	O	432	433	,	,	O	,	O	21	P	O
O	O	O	434	435	a	a	B-NP	DT	O	21	NMOD	O
O	O	O	436	443	process	process	I-NP	NN	O	13	PMOD	O
O	O	O	444	452	critical	critical	B-ADJP	JJ	O	21	NMOD	O
O	O	O	453	456	for	for	B-PP	IN	O	22	AMOD	O
O	O	O	457	458	T	T	B-NP	NN	O	26	NMOD	O
O	O	O	459	463	cell	cell	I-NP	NN	O	26	NMOD	O
O	O	O	464	470	growth	growth	I-NP	NN	O	23	PMOD	O
O	O	O	470	471	.	.	O	.	O	6	P	O

O	O	O	472	474	To	To	B-VP	TO	O	3	VMOD	O
O	O	O	475	482	further	further	I-VP	RB	O	3	VMOD	O
O	O	O	483	493	understand	understand	I-VP	VB	O	14	VMOD	O
O	O	O	494	497	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	498	507	molecular	molecular	I-NP	JJ	O	7	AMOD	O
O	O	O	508	511	and	and	I-NP	CC	O	7	AMOD	O
O	O	O	512	519	nuclear	nuclear	I-NP	JJ	O	8	NMOD	O
O	O	O	520	525	basis	basis	I-NP	NN	O	3	OBJ	O
O	O	O	526	529	for	for	B-PP	IN	O	8	NMOD	O
O	O	O	530	534	this	this	B-NP	DT	O	11	NMOD	O
O	O	O	535	544	synergism	synergism	I-NP	NN	O	9	PMOD	O
O	O	O	544	545	,	,	O	,	O	14	P	O
O	O	O	546	548	we	we	B-NP	PRP	O	14	SUB	O
O	O	O	549	553	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	554	562	explored	explore	I-VP	VBN	O	14	VC	O
O	O	O	563	566	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	567	576	induction	induction	I-NP	NN	O	15	OBJ	O
O	O	O	577	579	of	of	B-PP	IN	O	17	NMOD	O
T6	B-Entity	B-Entity	580	583	DNA	DNA	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	583	584	-	-	O	HYPH	I-protein	19	P	I-protein
O	O	O	584	591	binding	bind	B-VP	VBG	I-protein	22	NMOD	I-protein
O	O	O	592	600	proteins	protein	B-NP	NNS	I-protein	18	PMOD	I-protein
O	O	O	601	603	in	in	B-PP	IN	O	17	NMOD	O
O	O	O	604	610	highly	highly	B-NP	RB	B-cell_type	25	AMOD	B-cell_type
O	O	O	611	619	purified	purify	I-NP	VBN	I-cell_type	29	NMOD	I-cell_type
O	O	O	620	626	normal	normal	I-NP	JJ	I-cell_type	29	NMOD	I-cell_type
O	O	O	627	632	human	human	I-NP	JJ	I-cell_type	29	NMOD	I-cell_type
O	O	O	633	634	T	T	I-NP	NN	I-cell_type	29	NMOD	I-cell_type
O	O	O	635	640	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	O	641	649	signaled	signal	B-VP	VBN	O	29	NMOD	O
O	O	O	650	653	via	via	B-PP	IN	O	30	VMOD	O
O	O	O	654	657	the	the	B-NP	DT	O	38	NMOD	O
T7	B-Entity	B-Entity	658	661	CD3	CD3	I-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	662	665	and	and	O	CC	O	35	NMOD	O
O	O	O	665	666	/	/	B-NP	SYM	O	38	NMOD	O
O	O	O	666	668	or	or	O	CC	O	38	NMOD	O
O	O	O	669	672	CD2	CD2	B-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	673	681	proteins	protein	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	O	681	682	.	.	O	.	O	14	P	O

O	O	O	683	686	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	687	693	effect	effect	I-NP	NN	O	21	NMOD	O
O	O	O	694	696	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	697	710	transmembrane	transmembrane	B-NP	NN	O	5	NMOD	O
O	O	O	711	720	signaling	signaling	I-NP	NN	O	3	PMOD	O
O	O	O	721	723	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	724	725	T	T	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	O	726	731	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	732	736	with	with	B-PP	IN	O	5	NMOD	O
O	O	O	737	746	ionomycin	ionomycin	B-NP	NN	O	9	PMOD	O
O	O	O	746	747	,	,	O	,	O	21	P	O
O	O	O	748	751	and	and	O	CC	O	21	NMOD	O
O	O	O	751	752	/	/	B-NP	SYM	O	16	NMOD	O
O	O	O	752	754	or	or	O	CC	O	16	NMOD	O
O	O	O	755	757	sn	sn	B-NP	NN	O	16	NMOD	O
O	O	O	757	758	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	O	758	759	1	1	I-NP	CD	O	16	NMOD	O
O	O	O	759	760	,	,	I-NP	,	O	21	P	O
O	O	O	760	761	2	2	I-NP	CD	O	21	NMOD	O
O	O	O	762	772	dioctanoyl	dioctanoyl	I-NP	NN	O	21	NMOD	O
O	O	O	773	781	glycerol	glycerol	I-NP	NN	O	23	SUB	O
O	O	O	781	782	,	,	O	,	O	21	P	O
O	O	O	783	786	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	787	791	also	also	I-VP	RB	O	23	VMOD	O
O	O	O	792	802	determined	determine	I-VP	VBN	O	23	VC	O
O	O	O	802	803	.	.	O	.	O	23	P	O

O	O	O	804	807	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	808	817	emergence	emergence	I-NP	NN	O	7	SUB	O
O	O	O	818	820	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	821	828	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD	B-protein
O	O	O	829	836	binding	binding	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	837	845	proteins	protein	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	O	846	849	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	850	862	investigated	investigate	I-VP	VBN	O	7	VC	O
O	O	O	863	868	using	use	B-VP	VBG	O	7	VMOD	O
T2	B-Protein	B-Protein	869	880	interleukin	interleukin	B-NP	NN	B-protein	13	AMOD	B-protein
T2	I-Protein	I-Protein	880	881	-	-	I-NP	HYPH	O	13	P	O
T2	I-Protein	I-Protein	881	882	2	2	I-NP	CD	O	13	NMOD	O
T8	B-Entity	B-Entity	883	891	sequence	sequence	I-NP	NN	O	16	NMOD	O
T8	I-Entity	I-Entity	892	900	specific	specific	I-NP	JJ	O	13	AMOD	O
T8	I-Entity	I-Entity	901	916	oligonucleotide	oligonucleotide	I-NP	NN	O	16	NMOD	O
T8	I-Entity	I-Entity	917	923	probes	probe	I-NP	NNS	O	9	OBJ	O
O	O	O	924	926	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	927	930	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	931	946	electrophoretic	electrophoretic	I-NP	JJ	O	22	NMOD	O
O	O	O	947	955	mobility	mobility	I-NP	NN	O	22	NMOD	O
O	O	O	956	961	shift	shift	I-NP	NN	O	22	NMOD	O
O	O	O	962	967	assay	assay	I-NP	NN	O	17	PMOD	O
O	O	O	967	968	.	.	O	.	O	7	P	O

O	O	O	969	972	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	973	980	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	981	992	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	993	996	for	for	B-PP	IN	O	3	VMOD	O
O	O	O	997	1000	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1001	1006	first	first	I-NP	JJ	O	7	NMOD	O
O	O	O	1007	1011	time	time	I-NP	NN	O	4	PMOD	O
O	O	O	1012	1016	that	that	B-ADVP	IN	O	3	VMOD	O
T9	B-Entity	B-Entity	1017	1020	CD3	CD3	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1021	1028	antigen	antigen	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1028	1029	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	1029	1036	derived	derive	I-NP	VBN	O	13	NMOD	O
O	O	O	1037	1044	signals	signal	I-NP	NNS	O	16	NMOD	O
O	O	O	1045	1048	and	and	O	CC	O	16	NMOD	O
O	O	O	1049	1052	CD2	CD2	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	1053	1060	antigen	antigen	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	1060	1061	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	O	1061	1068	derived	derive	I-NP	VBN	O	19	NMOD	O
O	O	O	1069	1076	signals	signal	I-NP	NNS	O	20	SUB	O
O	O	O	1077	1080	are	be	B-VP	VBP	O	8	SBAR	O
O	O	O	1081	1092	synergistic	synergistic	B-ADJP	JJ	O	20	PRD	O
O	O	O	1093	1095	in	in	B-PP	IN	O	20	VMOD	O
O	O	O	1096	1104	inducing	induce	B-VP	VBG	O	22	PMOD	O
O	O	O	1105	1108	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	1109	1118	emergence	emergence	I-NP	NN	O	23	OBJ	O
O	O	O	1119	1121	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	1122	1135	transcription	transcription	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	1136	1143	factors	factor	I-NP	NNS	I-protein	26	PMOD	I-protein
O	O	O	1144	1148	that	that	B-NP	WDT	O	28	NMOD	O
O	O	O	1149	1153	bind	bind	B-VP	VBP	O	29	SBAR	O
O	O	O	1154	1156	to	to	B-PP	TO	O	30	VMOD	O
O	O	O	1157	1160	the	the	B-NP	DT	O	35	NMOD	O
O	O	O	1161	1163	NF	NF	I-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	1163	1164	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
O	O	O	1164	1167	AT1	AT1	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	O	1167	1168	,	,	O	,	O	45	P	O
O	O	O	1169	1171	AP	AP	B-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	1171	1172	-	-	B-NP	HYPH	I-protein	45	NMOD	I-protein
O	O	O	1172	1173	1	1	I-NP	CD	I-protein	38	NMOD	I-protein
O	O	O	1173	1174	,	,	O	,	O	45	P	O
O	O	O	1175	1178	and	and	O	CC	O	45	NMOD	O
O	O	O	1179	1181	NF	NF	B-NP	NN	B-protein	43	NMOD	B-protein
O	O	O	1181	1182	-	-	B-NP	HYPH	O	45	NMOD	O
O	O	O	1182	1184	kB	kB	I-NP	NN	B-DNA	45	NMOD	B-DNA
T10	B-Entity	B-Entity	1185	1190	sites	site	I-NP	NNS	I-DNA	31	PMOD	I-DNA
O	O	O	1191	1198	located	located	B-ADJP	JJ	O	45	NMOD	O
O	O	O	1199	1201	in	in	B-PP	IN	O	46	AMOD	O
O	O	O	1202	1205	the	the	B-NP	DT	O	52	NMOD	O
T11	B-Entity	B-Entity	1206	1214	promoter	promoter	I-NP	NN	B-DNA	52	NMOD	B-DNA
T11	I-Entity	I-Entity	1214	1215	/	/	B-NP	SYM	I-DNA	52	NMOD	I-DNA
T11	I-Entity	I-Entity	1215	1223	enhancer	enhancer	I-NP	NN	I-DNA	52	NMOD	I-DNA
T11	I-Entity	I-Entity	1224	1230	region	region	I-NP	NN	I-DNA	47	PMOD	I-DNA
O	O	O	1231	1233	of	of	B-PP	IN	O	52	NMOD	O
O	O	O	1234	1237	the	the	B-NP	DT	O	58	NMOD	O
T3	B-Protein	B-Protein	1238	1240	IL	IL	I-NP	NN	B-DNA	58	NMOD	B-DNA
T3	I-Protein	I-Protein	1240	1241	-	-	B-NP	HYPH	I-DNA	58	NMOD	I-DNA
T3	I-Protein	I-Protein	1241	1242	2	2	I-NP	CD	I-DNA	58	NMOD	I-DNA
O	O	O	1243	1247	gene	gene	I-NP	NN	I-DNA	53	PMOD	I-DNA
O	O	O	1247	1248	.	.	O	.	O	3	P	O

O	O	O	1249	1257	Moreover	Moreover	B-ADVP	RB	O	13	VMOD	O
O	O	O	1257	1258	,	,	O	,	O	13	P	O
O	O	O	1259	1271	cyclosporine	cyclosporine	B-NP	NN	O	13	SUB	O
O	O	O	1271	1272	,	,	O	,	O	3	P	O
O	O	O	1273	1275	at	at	B-PP	IN	O	3	NMOD	O
O	O	O	1276	1290	concentrations	concentration	B-NP	NNS	O	5	PMOD	O
O	O	O	1291	1298	readily	readily	B-VP	RB	O	8	VMOD	O
O	O	O	1299	1311	accomplished	accomplish	I-VP	VBN	O	6	NMOD	O
O	O	O	1312	1314	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	1315	1323	clinical	clinical	B-NP	JJ	O	11	NMOD	O
O	O	O	1324	1332	practice	practice	I-NP	NN	O	9	PMOD	O
O	O	O	1332	1333	,	,	O	,	O	3	P	O
O	O	O	1334	1337	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1338	1343	found	find	I-VP	VBN	O	13	VC	O
O	O	O	1344	1346	to	to	I-VP	TO	O	16	VMOD	O
O	O	O	1347	1354	inhibit	inhibit	I-VP	VB	O	14	VMOD	O
O	O	O	1355	1358	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1359	1368	emergence	emergence	I-NP	NN	O	16	OBJ	O
O	O	O	1369	1371	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1372	1377	these	these	B-NP	DT	O	24	NMOD	O
T12	B-Entity	B-Entity	1378	1381	DNA	DNA	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	1381	1382	-	-	O	HYPH	I-protein	24	NMOD	I-protein
O	O	O	1382	1389	binding	bind	B-VP	VBG	I-protein	24	NMOD	I-protein
O	O	O	1390	1398	proteins	protein	B-NP	NNS	I-protein	19	PMOD	I-protein
O	O	O	1399	1401	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	1402	1408	normal	normal	B-NP	JJ	B-cell_type	29	NMOD	B-cell_type
O	O	O	1409	1414	human	human	I-NP	JJ	I-cell_type	29	NMOD	I-cell_type
O	O	O	1415	1416	T	T	I-NP	NN	I-cell_type	29	NMOD	I-cell_type
O	O	O	1417	1422	cells	cell	I-NP	NNS	I-cell_type	25	PMOD	I-cell_type
O	O	O	1423	1431	signaled	signal	B-VP	VBN	O	29	NMOD	O
O	O	O	1432	1435	via	via	B-PP	IN	O	30	VMOD	O
O	O	O	1436	1440	cell	cell	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	O	1441	1448	surface	surface	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	1449	1457	proteins	protein	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	O	1458	1468	implicated	implicate	B-VP	VBN	O	34	NMOD	O
O	O	O	1469	1471	in	in	B-PP	IN	O	35	VMOD	O
O	O	O	1472	1479	antigen	antigen	B-NP	NN	O	42	NMOD	O
O	O	O	1479	1480	-	-	B-NP	HYPH	O	42	NMOD	O
O	O	O	1480	1489	dependent	dependent	I-NP	JJ	O	42	NMOD	O
O	O	O	1490	1491	T	T	I-NP	NN	O	42	NMOD	O
O	O	O	1492	1496	cell	cell	I-NP	NN	O	42	NMOD	O
O	O	O	1497	1507	activation	activation	I-NP	NN	O	36	PMOD	O
O	O	O	1508	1511	and	and	B-PP	CC	O	25	PMOD	O
O	O	O	1512	1514	in	in	B-PP	IN	O	25	PMOD	O
O	O	O	1515	1516	T	T	B-NP	NN	B-cell_type	46	NMOD	B-cell_type
O	O	O	1517	1522	cells	cell	I-NP	NNS	I-cell_type	44	PMOD	I-cell_type
O	O	O	1523	1533	stimulated	stimulate	B-VP	VBN	O	46	NMOD	O
O	O	O	1534	1536	by	by	B-PP	IN	O	47	VMOD	O
O	O	O	1537	1549	mobilization	mobilization	B-NP	NN	O	54	NMOD	O
O	O	O	1550	1552	of	of	B-PP	IN	O	49	NMOD	O
O	O	O	1553	1561	cellular	cellular	B-NP	JJ	O	52	NMOD	O
O	O	O	1562	1569	calcium	calcium	I-NP	NN	O	50	PMOD	O
O	O	O	1570	1573	and	and	O	CC	O	54	NMOD	O
O	O	O	1574	1584	activation	activation	B-NP	NN	O	48	PMOD	O
O	O	O	1585	1587	of	of	B-PP	IN	O	54	NMOD	O
O	O	O	1588	1595	protein	protein	B-NP	NN	B-protein	58	NMOD	B-protein
O	O	O	1596	1602	kinase	kinase	I-NP	NN	I-protein	58	NMOD	I-protein
O	O	O	1603	1604	C	C	I-NP	NN	I-protein	55	PMOD	I-protein
O	O	O	1604	1605	.	.	O	.	O	13	P	O
